Biznews9d
🔒 Novo’s insulin pen phase-out sparks CompCom probe as diabetes remains a silent killer among SA women
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
Medscape11d
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
The patient satisfaction survey results were based on the responses of the patients who completed the study: 35 patients in the pen group and 40 patients in the vial and syringe group. Demographic ...